Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19
Khan Sharun, Ruchi Tiwari, Mohd I. Yatoo, et al.
Narra J (2022) Vol. 2, Iss. 3, pp. e92-e92
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Efficacy and safety of tixagevimab‐cilgavimab as pre‐exposure prophylaxis for COVID‐19: A systematic review and meta‐analysis
Arto Yuwono Soeroto, Theo Audi Yanto, Andree Kurniawan, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 2
Closed Access | Times Cited: 33
Antiviral Molecular Targets of Essential Oils against SARS-CoV-2: A Systematic Review
Muhammad Iqhrammullah, Diva Rayyan Rizki, Agnia Purnama, et al.
Scientia Pharmaceutica (2023) Vol. 91, Iss. 1, pp. 15-15
Open Access | Times Cited: 24
Quercetin for the treatment of COVID‐19 patients: A systematic review and meta‐analysis
Huzaifa Ahmad Cheema, Aruba Sohail, Areej Fatima, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 2
Closed Access | Times Cited: 23
Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease: a multicenter, retrospective, cohort study
Benchen Rao, Daming Wang, Mengzhao Yang, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
SARS‐CoV‐2 nucleocapsid: Biological functions and implication for disease diagnosis and vaccine design
Faezeh Maghsood, Ahmad Ghorbani, Hamidreza Yadegari, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 3
Closed Access | Times Cited: 14
COVID-19 pandemic sheds a new research spotlight on antiviral potential of essential oils – A bibliometric study
Binawati Ginting, Williams Chiari, Teuku Fais Duta, et al.
Heliyon (2023) Vol. 9, Iss. 7, pp. e17703-e17703
Open Access | Times Cited: 13
A comprehensive health effects assessment of the use of sanitizers and disinfectants during COVID-19 pandemic: a global survey
Fallah Hashemi, Lori Hoepner, Farahnaz Soleimani Hamidinejad, et al.
Environmental Science and Pollution Research (2023) Vol. 30, Iss. 28, pp. 72368-72388
Open Access | Times Cited: 12
Geographical variations and district-level factors associated with COVID-19 mortality in Indonesia: a nationwide ecological study
Henry Surendra, Danarastri Paramita, Nora N. Arista, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 11
XBB.1.5: A new threatening SARS-CoV-2 Omicron subvariant
Md. Aminul Islam, Fatema Hasan Kaifa, Deepak Chandran, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 10
To PCR or not? The impact of shifting policy from PCR to rapid antigen tests to diagnose COVID-19 during the omicron epidemic: a nationwide surveillance study
Hsin Chi, Nan‐Chang Chiu, Chung-Chu Chen, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 10
Probiotics for the prevention and treatment of COVID-19: a rapid systematic review and meta-analysis
Aruba Sohail, Huzaifa Ahmad Cheema, Maidah Sohail Mithani, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 10
The determinants of COVID-induced brain dysfunctions after SARS-CoV-2 infection in hospitalized patients
Shahwar Yasir, Yu Jin, Fuleah A. Razzaq, et al.
Frontiers in Neuroscience (2024) Vol. 17
Open Access | Times Cited: 3
The role of N-acetylcysteine in decreasing neutrophil-lymphocyte ratio in COVID-19 patients: A double-blind, randomized controlled trial
Nurhasan Agung Prabowo, Marcellino A. Megantara, Hendrastutik Apriningsih
Narra J (2023) Vol. 3, Iss. 2, pp. e121-e121
Open Access | Times Cited: 9
Clinical Profile and Risk Factors for Severe COVID-19 in Hospitalized Patients from Rio de Janeiro, Brazil: Comparison between the First and Second Pandemic Waves
Luciane Almeida Amado Leon, Wagner Luís da Costa Nunes Pimentel Coelho, Arthur Daniel Rocha Alves, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2568-2568
Open Access | Times Cited: 7
Clinical characteristics and factors associated with COVID-19-related mortality and hospital admission during the first two epidemic waves in 5 rural provinces in Indonesia: A retrospective cohort study
Henry Surendra, C. Yekti Praptiningsih, Arina M. Ersanti, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0283805-e0283805
Open Access | Times Cited: 7
Clinical efficacy of anti‐SARS‐CoV‐2 monoclonal antibodies in preventing hospitalisation and mortality among patients infected with Omicron variants: A systematic review and meta‐analysis
Danijela Miljanovic, Andja Ćirković, Ivana Lazarević, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 4
Closed Access | Times Cited: 5
Assessment of post-COVID-19 fatigue among female survivors 2 years after hospital discharge: a nested case–control study
Yidan Ye, Chuyue Xiong, Yang Dai, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Molecular modeling of some commercially available antiviral drugs and their derivatives against SARS-CoV-2 infection
Mohammad Arman, Safaet Alam, Rifat Alam Maruf, et al.
Narra J (2024) Vol. 4, Iss. 1, pp. e319-e319
Open Access | Times Cited: 1
Efficacy of therapeutic plasma exchange in patients with severe COVID‐19: A systematic review and meta‐analysis
Omar Ahmed Abdelwahab, Rehab Adel Diab, Khaled Saad Elsaeidy, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 3
Closed Access | Times Cited: 4
Engineered Cross-Linked Silane with Urea Polymer Thin Durable Coatings onto Polymeric Films for Controlled Antiviral Release of Activated Chlorine and Essential Oils
Elisheva Sasson, Omer Agazani, Eyal Malka, et al.
Journal of Functional Biomaterials (2023) Vol. 14, Iss. 5, pp. 270-270
Open Access | Times Cited: 4
SARS‐CoV‐2 neutralising antibody therapies: Recent advances and future challenges
Mingtao Liu, Zhiman Liang, Zhangkai J. Cheng, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 5
Closed Access | Times Cited: 4
Characteristic profiles of patients with diabetes mellitus and COVID-19 during the second epidemic wave in East Java, Indonesia: a retrospective study
Batari Retno Minanti, Soebagijo Adi Soelistijo, Agung Pranoto
Bali Medical Journal (2023) Vol. 12, Iss. 1, pp. 1120-1126
Open Access | Times Cited: 4
Co-incidence of COVID-19 and hepatocellular carcinoma during pregnancy: Double punches to disease severity and mortality?
Azzaki Abubakar, Fauzi Yusuf, Sarah Firdausa, et al.
Narra J (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 3
4’-fluorouridine as a potential COVID-19 oral drug?: a review
Abdul Hawil Abas, Trina Ekawati Tallei, Fatimawali Fatimawali, et al.
F1000Research (2023) Vol. 11, pp. 410-410
Open Access | Times Cited: 2
Human‐virus protein‐protein interactions maps assist in revealing the pathogenesis of viral infection
Huimin Chen, Jia‐Xin Liu, Di Liu, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top